|
Feb 20
|
3 Reasons to Avoid DGX and 1 Stock to Buy Instead
|
|
Feb 19
|
Hims & Hers Health surges on acquisition for at-home testing
|
|
Feb 19
|
CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall
|
|
Feb 19
|
Is There An Opportunity With Quest Diagnostics Incorporated's (NYSE:DGX) 50% Undervaluation?
|
|
Feb 14
|
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
|
|
Feb 13
|
Quest Diagnostics to Host Investor Day on March 19, 2025
|
|
Feb 13
|
Grail and Quest Diagnostics to offer Galleri test to US physicians
|
|
Feb 12
|
Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts
|
|
Feb 12
|
Why Grail (GRAL) Stock Is Jumping Today
|
|
Feb 12
|
GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
|
|
Feb 10
|
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
|
|
Feb 10
|
Quest Diagnostics Stock to Gain From Innovation Amid Industry Threats
|
|
Feb 10
|
NVST Stock Up on Q4 Earnings and Revenue Beat, Operating Margin Crashes
|
|
Jan 3
|
Why Quest Diagnostics (DGX) is Poised to Beat Earnings Estimates Again
|
|
Jan 2
|
Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
|
|
Dec 31
|
Should You Hold Quest Diagnostics Stock in Your Portfolio Now?
|
|
Oct 10
|
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
|
|
Oct 9
|
Amwell Shares Rise After Expansion of Portfolio With Hello Heart
|
|
Oct 9
|
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?
|
|
Oct 9
|
Should You Add Quest Diagnostics Stock to Your Portfolio Right Now?
|